Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
Clovis CEO Patrick Mahaffy settles up on SEC charges of lying about the roci data — and it won’t cost much
7 years ago
GSK poaches new drug development chief Chris Corsico from Boehringer, dividing R&D into two groups
7 years ago
Another scientist pleads guilty for his role in a scheme to sell GSK's trade secrets in China
7 years ago
China
Pharma
MSK's José Baselga steps off Bristol-Myers' board as the industry debates the controversy over industry ties
7 years ago
SEC charges that hedge fund manager (and priest) relied on false claims to promote a Ligand short attack
7 years ago
Pharma
Scouting early-stage oncology plays, biopharma vets Detlev Biniszkiewicz, Scott Chappel make VC debut at MPM
7 years ago
Financing
Sanofi swaps top execs with Bayer, triggering a reorganization that puts China in the headlights
7 years ago
China
Joining the exodus at Gilead, CMO Andrew Cheng makes the switch to biotech CEO — triggering a cross-country move for Akero
7 years ago
The Broad wins another — perhaps final — battle in the war over Feng Zhang's CRISPR patents
7 years ago
Pharma
SEC accuses biotech billionaire Phillip Frost of joining a 'pump-and-dump' scheme that netted $27M
7 years ago
A star cancer scientist failed to disclose industry payments over the years — does that matter so much?
7 years ago
Revolving door between industry and FDA continues to spin
7 years ago
Pharma
Third Rock woos top Roche scientist Sanjay Keswani to the helm of biotech startup Rheos Medicines
7 years ago
Startups
Partnering with Amgen vet Sean Harper, veteran VC Beth Seidenberg unveils a $320M fund and a unique focus on…wait for it…LA
7 years ago
Financing
David Schenkein is passing the reins at Agios to Jackie Fouse after a star-making 10-year run
7 years ago
Once charged with speeding up Eli Lilly’s slow-mo R&D group, Anne White is handed the reins at Lilly Oncology
7 years ago
Coming to America: Rehan Verjee jumps up to top US healthcare post for Merck KGaA in high-level revamp
7 years ago
Amgen vet Laura Hamill takes commercial reins at Gilead amid executive shakeup
7 years ago
Bristol-Myers promotes a commercial player to top sales job — replacing new Amgen exec Murdo Gordon
7 years ago
Vivek Ramaswamy bags $100M in risk capital to back his latest PhIII gamble at Dermavant — while Urovant dives into gene therapy
7 years ago
Financing
Sangamo researcher charged with insider trading in latest round of SEC accusations leveled at a biotech exec
7 years ago
Pharma
As Shkreli attorney Greebel heads to his own prison cell, the bad boy of biotech is still skewering enemies in new blog
7 years ago
'Gap years' are for adults, too: Ex-Foundation exec Steve Kafka joins Third Rock after globetrotting break
7 years ago
One more gig: Steven Paul decides to extend a 35-year track record with one last shot at a big development program
7 years ago
Startups
First page
Previous page
84
85
86
87
88
89
90
Next page
Last page